Literature DB >> 18758701

Late-onset and atypical presentation of Pneumocystis carinii pneumonia in a renal transplant recipient.

Jordan Y Z Li1, Tuck Y Yong, David I Grove, P Toby H Coates.   

Abstract

Pneumocystis jivorecii (formerly known as carinii) pneumonia (PCP) is potentially a life-threatening opportunistic infection after organ transplantation, occurring most frequently in the first 12 months, where the incidence rate is several-fold higher than in later years. PCP typically presents with fever, cough, dyspnoea and hypoxia. In organ transplant recipients, the onset of symptoms is generally more fulminant compared to patients infected with the human immunodeficiency virus. We present a patient who developed PCP five years after a renal transplantation. His presentation was characterised by atypical symptoms and an indolent onset. Previous acute vascular rejection, ongoing maintenance prednisolone usage, cytomegalovirus seropositivity and past tuberculous infection may have predisposed this patient to PCP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18758701     DOI: 10.1007/s10157-008-0079-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  17 in total

1.  Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

Authors:  B D Kahan; B A Julian; M D Pescovitz; Y Vanrenterghem; J Neylan
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

Review 2.  Pneumocystis carinii and parasitic infections in transplantation.

Authors:  J A Fishman
Journal:  Infect Dis Clin North Am       Date:  1995-12       Impact factor: 5.982

3.  Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience.

Authors:  J Dominguez; K Mahalati; B Kiberd; V C McAlister; A S MacDonald
Journal:  Transplantation       Date:  2000-10-27       Impact factor: 4.939

4.  Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued?

Authors:  S M Gordon; S P LaRosa; S Kalmadi; A C Arroliga; R K Avery; L Truesdell-LaRosa; D L Longworth
Journal:  Clin Infect Dis       Date:  1999-02       Impact factor: 9.079

5.  Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study.

Authors:  M Radisic; R Lattes; J F Chapman; M del Carmen Rial; O Guardia; F Seu; P Gutierrez; J Goldberg; D H Casadei
Journal:  Transpl Infect Dis       Date:  2003-06       Impact factor: 2.228

6.  Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.

Authors: 
Journal:  Lancet       Date:  1995-05-27       Impact factor: 79.321

7.  Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids.

Authors:  A M Hardy; C P Wajszczuk; A F Suffredini; T R Hakala; M Ho
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

8.  Pneumocystis carinii pneumonia in HIV-negative immunocompromised adults.

Authors:  J G Gerrard
Journal:  Med J Aust       Date:  1995-03-06       Impact factor: 7.738

9.  A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

Authors: 
Journal:  Transplantation       Date:  1996-04-15       Impact factor: 4.939

10.  Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases.

Authors:  S M Arend; F P Kroon; J W van't Wout
Journal:  Arch Intern Med       Date:  1995 Dec 11-25
View more
  3 in total

1.  Pneumocystis pneumonia (PCP) and Pneumocystis jirovecii carriage in renal transplantation patients: a single-centre experience.

Authors:  Matthias Maruschke; Diana Riebold; Martha Charlotte Holtfreter; Martina Sombetzki; Steffen Mitzner; Micha Loebermann; Emil Christian Reisinger; Oliver W Hakenberg
Journal:  Wien Klin Wochenschr       Date:  2014-09-19       Impact factor: 1.704

2.  Metagenomic Next-Generation Sequencing in Diagnosis of a Case of Pneumocystis jirovecii Pneumonia in a Kidney Transplant Recipient and Literature Review.

Authors:  Jie Chen; Ting He; Xiujun Li; Xue Wang; Li Peng; Liang Ma
Journal:  Infect Drug Resist       Date:  2020-08-13       Impact factor: 4.003

3.  Successful treatment of a kidney transplant patient with COVID-19 and late-onset Pneumocystis jirovecii pneumonia.

Authors:  Jing Peng; Ming Ni; Dunfeng Du; Yanjun Lu; Juan Song; Weiyong Liu; Na Shen; Xiong Wang; Yaowu Zhu; Bruce A Vallance; Ziyong Sun; Hong Bing Yu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-12-15       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.